SenesTech, Inc. announced the issuance of its patent on “reducing the reproductive capacity of mammals.”
“This intellectual property is a key aspect of ContraPest, SenesTech’s flagship product that targets the reproductive capabilities of Norway and roof rats,” said SenesTec.
“The patent application was filed August 23, 2013, and has been issued today with patent number US 9,956,235.”
Cheryl Dyer, chief research officer of SenesTech, said: “This patent is the key of our intellectual property portfolio.
“It protects use of the combination of two active ingredients in causing both ovary and testis to fail.
“To simplify the science, rats that consume our bait, ContraPest, do not reproduce, ultimately reducing the population.”
Loretta Mayer, CEO of SenesTech, said: “This patent issue underlies the foundation of our fertility control technology that can be directly targeted not only to rats, but also developed for other pest mammals in our pipeline.
“The anchor of our ContraPest intellectual property portfolio is comprised of the combination of two composition patents, two delivery device patents, exclusive use of the two active ingredients for the purpose of rodent control, and trade secrets wrapping our manufacturing and quality control protocols.”